Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Jiankang Yuan wins the "Most Growing Listed Company in the Greater Health Industry" award in the China Listed Company Reputation List
Published Time：
2020-12-04
Recently, the "2020 Ninth China Listed Companies Summit Forum," a major event of the China Capital Market Annual Conference hosted by the Daily Economic News, was grandly held in Shenzhen. During the forum, the highly anticipated "2020 China Listed Companies Reputation List Honor Ceremony," featuring 17 major lists, concluded. With its rapid, high-quality growth and huge potential in innovative R&D in the Greater Health sector, Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan") won an important capital market award—the "Most Growing Listed Company in the Greater Health Industry" award.
From the first China Listed Companies Reputation List selection to the present, ten sessions have been held. Over these ten years, the Reputation List has continuously improved, and it has now become an indispensable award in the Chinese capital market. According to the organizers, this year's "China Listed Companies Reputation List" selection covered the three major global capital markets: A-shares, H-shares, and US stocks, with fierce competition among participating companies. The Reputation List uses multiple rounds of screening, including online nominations, big data screening, data model screening, and public voting plus expert review panel review, to ultimately select the winning companies. The online nomination and public voting stages, in which investors directly participate, demonstrate that the Reputation List can maximally reflect the reputation of listed companies in the eyes of investors, signifying that the listed companies possess a high-quality, high-investment-value brand image in the eyes of investors.
Leveraging authoritative, scientific, and professional R&D scientific concepts, as well as systematic, in-depth, and comprehensive supporting publicity, Health Yuan Group has been committed to cultivating the domestic Greater Health industry, and in recent years has secured a place in the domestic inhalation preparation field. According to publicly available information, Health Yuan currently has multiple products successfully launched in the respiratory field, with most provinces completing network registration, and the marketing team is basically complete. Multiple inhalation preparations, such as ipratropium bromide solution for inhalation and budesonide suspension for inhalation, have also obtained drug registration certificates. The peak sales of the key product, budesonide inhalation suspension, are expected to exceed 1.5 billion yuan and reach around 2 billion yuan. In this regard, multiple research institutions have expressed optimism about the continued realization of the Group's R&D capabilities in the inhalation preparation field. In the future, with coverage of high-potential respiratory hospitals nationwide, Health Yuan is expected to become a leader in domestic inhalation preparations. This award is an authoritative recognition by the capital market of Health Yuan Group's comprehensive strength and future growth potential.
The reputation of investors is more valuable than any award. Health Yuan Pharmaceutical Group, after more than 20 years of development, has always taken the revitalization of the national pharmaceutical industry as its mission and aims to become one of China's best pharmaceutical companies. Through steady operation, it has created numerous high-quality products with national recognition, earning the praise and acclaim of millions of consumers and investors. In recent years, it has continuously improved its layout in the "Greater Health Industry," enriching its product line to meet the growing consumer demand for high-quality products. Health Yuan will remain true to its original aspiration, adhere to quality, focus on R&D, and continue to give back to society through action!
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.